Table 7 –
Complete response to treatment within the 1st year
| RT + paclitaxel + trastuzumab (n = 18) |
RT + paclitaxel (n = 37) | |||
|---|---|---|---|---|
| n (%) | 95% CI | n (%) | 95% CI | |
| Complete response | 13 (72.2) | (46.5%, 90.3%) | 25 (67.6) | (50.2%, 82.0%) |
| No response | 5 (27.8) | 12 (32.4) | ||
CI = confidence interval; RT = radiotherapy.
Ten patients were not evaluable for response; the reasons are as follows: ten patients died without a response evaluation (two trastuzumab patient and eight no trastuzumab patients).